Since the beginning of the HIV epidemic, scientists, doctors, and public health experts have spent decades trying to understand the virus and control its spread. Modern treatments now allow people ...

CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV. A Miracle cancer therapy that involves engineering a patient’s own ...

HIV exhausts the body's immune system by overactivating it, despite effective antiviral treatment. Researchers from Linköping University in Sweden have conducted cell studies showing that an existing ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...

A Norwegian man who lived with HIV for more than a decade has become the 10th person in the world confirmed to be in long-term remission from the virus, according to new research. The 63-year-old man, ...

Highlights:Scientists at La Jolla Institute for Immunology and Scripps Research have developed an HIV vaccine that trains immune cells to see past ...

One-time CAR-T cell therapy controlled HIV in some patients after stopping antiretroviral drugs More study needed to confirm results, identify best candidates, researchers say Findings presented at ...

Scientists are tweaking a powerful cancer therapy in hopes it could fight HIV instead, by supercharging patients' own immune cells. On Tuesday, researchers said a single dose of those revved-up cells ...

The human immunodeficiency virus (HIV) is a type of retrovirus called a lentivirus. HIV infection leads, without treatment, to acquired immunodeficiency syndrome (AIDS), which is a progressive failure ...